Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2013-05-31
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MultiPoint Pacing Programming Guided by Noninvasive Hemodynamics
NCT02064751
Characterization of Cardiac Hemodynamics During MultiSite Pacing
NCT01564186
MultiPoint Pacing Mapping Study
NCT02547207
MultiPoint Pacing™ Post Market Study
NCT02832622
QP ExCELs: MultiPole Pacing (MPP) Sub-Study
NCT03155724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
MultiPoint Pacing programming based on hemodynamics
CRT device implant with MultiPoint Pacing
Hemodynamic measurements for CRT device programming
Hemodynamic measurements for CRT device programming
CRT device implant with MultiPoint Pacing
MultiPoint Pacing programming without hemodynamics
CRT device implant with MultiPoint Pacing
CRT device programming without hemodynamics
CRT device implant with MultiPoint Pacing
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Hemodynamic measurements for CRT device programming
CRT device implant with MultiPoint Pacing
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have the ability to provide informed consent for study participation and be willing and able to comply with the Clinical Investigation Plan (CIP) described evaluations and follow-up schedule
Exclusion Criteria
* Be in NYHA IV functional class
* Have a recent myocardial infarction within 40 days prior to enrollment
* Have undergone cardiac bypass surgery or coronary revascularization procedure within 3 months prior to enrollment or be scheduled for such procedures in the following 7 months
* Have had a recent CVA or TIA within 3 months prior to enrollment
* Have had intravenous inotropic support in the last 30 days
* Be less than 18 years of age
* Be pregnant or planning to become pregnant during the duration of the investigation.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Medical Devices
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Carlo Pappone, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Maria Cecilia Hospital, GVM Care & Research
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Maria Cecilia Hospital, GVM Care & Research
Cotignola, RA, Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CRD_684
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.